Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty : -Anin myocardial infarction registry-

Circulation Journal

Volumn 73, Issue 2, 2009, Pages 323-329

  Kruk, Mariusz ^a   Przyłuski, Jakub ^a   Kalińczuk, Ł Ukasz ^a   Prȩgowski, Jerzy ^a   Ka̧dziela, Jacek ^a   Kaczmarska, Edyta ^a   Petryka, Joanna ^a   Kȩpka, Cezary ^a   Kłopotowski, Mariusz ^a   Chmielak, Zbigniew ^a   Ciszewski, Andrzej ^a   Demkow, Marcin ^a   Karcz, Maciej ^a   Witkowski, Adam ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Hemoglobin; Inflammation; Leukocytes; Myocardial infarction; Primary angioplasty

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 59449096547     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0370     Document Type: Article

References (20)

1. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042 - 2049.
2. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547 - 553.
3. Turitto VT, Weiss HJ. Red blood cells: Their dual role in thrombus formation. Science 1980; 207: 541 - 543.
4. Kershenovich S, Modiano M, Ewy GA. Markedly decreased coronary blood flow in secondary polycythemia. Am Heart J 1992; 123: 521 - 523.
5. Lowe GD, Forbes CD. Blood rheology and thrombosis. Clin Haematol 1981; 10: 343 - 367.
6. Kruk M, Karcz M, Przyłuski J, Bekta P, Kȩpka C, Kalińczuk Ł, et al. White blood cell count adds prognostic information to the Thrombolysis in Myocardial Infarction risk index in patients following primary percutaneous coronary intervention. Int J Cardiol 2007; 116: 376 -382.
7. Kruk M, Karcz M, Przyłuski J, Bekta P, Kȩpka C, Kalińczuk Ł, et al. White blood cell count on admission and mortality in patients treated with primary percutaneous intervention (ANIN Myocardial Infarction Registry). Post Kardiol Interw 2007; 3,4: 193 - 198.
8. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 1973; 4: 576 - 581.
9. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler Thromb Vasc Biol 2005; 25: 658.
10. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998; 31: 1217 - 1225.
11. Hordijk-Trion M, Lenzen M, Wijns W, de Jaegere P, Simoons ML, Scholte op Reimer WJ, et al; EHS-CR Investigators. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: Results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J 2006; 27: 671 - 678.
12. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, Wilson AC; Myocardial Infarction Data Acquisition system (MIDAS #8) Study Group. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144: 636 - 641.
13. Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate; meta-analysis of prospective studies of coronary heart disease. Eur Heart J 2000; 21: 512- 520.
14. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol 2004; 44: 1533 - 1542.
15. Singla I, Zahid M, Good CB, Macioce A, Sonel AF. Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. Am J Cardiol 2007; 99: 1119 - 1121.
16. Hebert PC, Wells G, Blaj chman MA, Marshall J, Martin C, Pagliarello G, et al. A multicentre, randomised, controlled clinical trial of transfusion requirements in critical care: Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409 - 417.
17. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230 - 1236.
18. Núñez JE, Núñez E, Bertomeu V, Fácila L, Sanchis J, Bodí V, et al. Prognostic value of baseline white blood cell count in patients with acute myocardial infarction and ST segment elevation. Heart 2005; 91: 1094 - 1095.
19. Madjid M, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: Implications for risk assessment. J Am Coll Cardiol 2004; 44: 1945 - 1956.
20. Harlan JM, Winn RK. Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. Crit Care Med 2002; 30(Suppl): S214 -S219.